🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting news! Our CEO George Eleftheriou is about to take the stage at the Sachs Autumn Life Sciences Week Sachs Associates to share more about Feel Therapeutics. Stay tuned! #Sachs_BEF #Sachs_HTI #LifeSciences #FeelTherapeutics

🚀 Exciting start at HLTH! 🌟 The Feel Therapeutics team is at Booth 5256 (Kiosk 10). Come and visit us to grab a coffee together and explore our digital precision medicine platform and solutions! #HLTH2023 #FeelTherapeutics #healthcare #healthinnovation #futureofhealth

We’re thrilled to share that Feel Therapeutics has been named a Quarter Finalist Rising Star at the Digital Health Hub Foundation during HLTH! 🚀 Onward and upward #FeelTeam! 🌟 #FeelTherapeutics #HealthCareInnovation #DigitalHealthAwards

We're thrilled to announce that we're proud partners of the upcoming 6th Neuropsychiatric Drug Development Summit. Join us there as we embark on our collective journey to advance healthcare innovation at this exceptional summit. #NeuropsychiatricDrugDevelopment

🌍 On #WorldMentalHealthDay, we're thrilled to be at HLTH, uniting the entire health ecosystem for innovation and transformation. At Feel Therapeutics, we're on a mission to revolutionize #MentalHealthCare. Join our journey to reshape the landscape bit.ly/46AnEJc🎗️

Today, our Co-Founder & CTO Haris Tsirmpas and our VP of Clinical Operations Sharon Kaplow will be at the #DigitalBiomarkersDigitalMeasurements East Summit! Excited to dive into the exciting world of #digitalbiomarkers! #DigitalHealth #DigitalPrecisionMedicine #MentalHealth

🎉 Big News! 🎉 Our co-founders George Eleftheriou & Haris Tsirmpas have been included on the Fortune's 40 under 40 list by Fortune Greece , for another year! We couldn't be prouder. 🙌 #Fortune40Under40 #MentalHealth #Healthcare #FeelTherapeutics #40Under40 bit.ly/3QH0GuR

Greetings from Feel Therapeutics at the CNS Summit 2023! 🚀 The energy at #CNSSummit2023 is palpable, and it's been fantastic reconnecting with familiar faces and meeting new ones within the industry. 🤝 #DigitalPrecisionMedicine #FeelTheraputics George Eleftheriou Haris Tsirmpas

Today, our CEO, George Eleftheriou, will be joining an esteemed panel at the Johnson & Johnson Innovation JLABS Symposium for #PrecisionMedicine. The panel will focus on #DigitalApplications in Real-World Evidence Studies! 📹Tune in here: lnkd.in/d9atQRfZ #digitalprecisionmedicine

🧠💸Feel Therapeutics Brings Michel Vounatsos as Chairman Of The Advisory Board, and Secures New Funding to Advance Digital Precision Medicine for Mental Health. (Feel Therapeutics) . . 🔗feeltherapeutics.com/post/funding-k… . . #mentalhealth #behavioralhealth #funding

The Greek tech ecosystem keeps growing strong. Stories from Marathon Venture Capital, Found.ation, Halcyon, Piramidal, BetterBasket, Blueground, Harbor Lab, J.P. Morgan, Feel Therapeutics and Ion Ioannou.

We are excited to welcome Michel Vounatsos and Amy Kruse to our team!🎉We have also secured new #funding from Satori Capital, Metavallon et al. Read more here bit.ly/48Vh7dg

Why do we Need Wearables in Mental Health?⌚️Find out here: bit.ly/42i4NBO

Have you ever imagined that tracking your mental health could be as simple as counting your steps? 🚶‍♂️ Studies hint at a strong correlation between smartphone-tracked behaviors and mental health status. Explore the article here: bit.ly/48hKkhK

Our CEO, George Eleftheriou, joined the panel at the Johnson & Johnson Innovation -JLABS Symposium for Precision Medicine, where they discussed the use of digital applications for real-world evidence studies. 💡Watch the discussion here: bit.ly/42sEwAJ

Read the article in MedCity News about how Pharmaceutical companies use Feel therapeutics' Digital Precision Medicine Platform to monitor the mental state of participants in clinical trials of behavioral medications👇

Exciting News! 🎉 We're happy to announce the granting of our 2nd US Patent for Emotion AI Technology, titled “Method for detecting and recognizing an emotional state of a user”. ➡️Read more here: bit.ly/4a7ishq

📣 Today, Feel Therapeutics VP of Clinical Operations, Sharon Kaplow, will be discussing the Implementation of Integrated Evidence plans in clinical settings for DHTs at DiMe's seminar series! ▶️Tune in by following this link: bit.ly/3xSGAa0

Our CEO, George Eleftheriou, is representing Feel Therapeutics at the Mental & Brain Health Tech Tour in Lisbon, Portugal on May 2 & 3! 👉Join him in the panel 'Therapeutics Solutions' and learn all about our work!

We're excited to announce that Feel Therapeutics is among the winners of the Mental Brain & Health Tech Tour! 🎉